Treatment of Sarcopenia

First-Line Treatment Approach

Resistance training should be the cornerstone of sarcopenia treatment, as recommended by the American Diabetes Association, for older adults with sarcopenia 1, 2
Endurance training should be encouraged for all older adults with sarcopenia, according to the European Society for Clinical Nutrition and Metabolism 3, 2
A combination of aerobic activity, weight-bearing exercise, and resistance training is recommended for those who can safely engage in such activities, as suggested by the American Diabetes Association 1, 4

Comprehensive Treatment Protocol

Implement progressive resistance training 2-3 times per week, incorporating aerobic exercise to improve insulin sensitivity and weight-bearing exercises to prevent bone loss, as recommended by the Journal of the American Geriatrics Society 2, 5, 4
Ensure daily protein intake >1.0 g/kg body weight, distributing protein intake throughout the day, with 20-30g per meal, and consider specific nutrients that support muscle health, such as leucine-rich proteins, as suggested by the Gut Microbes journal 6

Special Considerations

Avoid weight loss diets during periods of active inflammation or illness, as this may accelerate muscle loss, according to the European Society for Clinical Nutrition and Metabolism 3, 2
Monitor for malnutrition, which is associated with decreases in activities of daily living, grip strength, and physical performance, as recommended by the American Diabetes Association 4

Common Pitfalls to Avoid

Focusing solely on weight loss in older adults with obesity without addressing muscle preservation, as warned by the Journal of the American Geriatrics Society and the European Society for Clinical Nutrition and Metabolism 5, 2
Inadequate protein intake during weight loss attempts, which accelerates muscle loss, as cautioned by the Journal of the American Geriatrics Society and the American Diabetes Association 5, 4
Neglecting resistance training, which is essential for maintaining and building muscle mass, as emphasized by the American Diabetes Association and the European Society for Clinical Nutrition and Metabolism 1, 2

Sarcopenia Prevention and Treatment

Definition and Characteristics

The American College of Nutrition defines sarcopenia as a progressive muscle disease characterized by the loss of muscle mass and strength, common in older adults but not inevitable 7
Sarcopenia is clinically defined as a total muscle mass ≥2 standard deviations below that of a comparable young adult, with a reduction in muscle cross-sectional area 8
It is associated with negative health outcomes such as frailty, falls, functional decline, and mortality 7

Epidemiology and Progression

From the age of 40, there is an 8% decrease in muscle mass per decade, increasing to 15% per decade from the age of 70 7
It is estimated that between 10-40% of community-dwelling older adults have sarcopenia, depending on the definition used 7

Causes of Sarcopenia

Nutritional factors, including inadequate protein and energy intake, malabsorption, and micronutrient deficiencies, contribute to the development of sarcopenia 7
Possible deficiencies of B vitamins that affect neuromuscular function may also contribute to sarcopenia 9

Prevention and Treatment

The European Society for Clinical Nutrition and Metabolism recommends nutritional interventions and physical activity as the most effective ways to delay or reverse sarcopenia 7
Addressing potential B vitamin deficiencies that may affect neuromuscular function is also important 10

Complications of Sarcopenia

Loss of functional independence and mobility 8
Increased risk of falls and related fractures 8

Considerations for Special Populations

The combination of obesity and sarcopenia (obese sarcopenia) results in a worse health and functional capacity state than either condition alone 7
Older adults are at risk of malnutrition and deficiency states that may have causal or exacerbating connections with sarcopenia 8
It is essential to consider the interactions between medications and nutrients in older adults with polypharmacy 7

Sarcopenia Prevention and Treatment Guidelines

Nutrition and Supplementation

Adequate vitamin D and omega-3 fatty acid intake may help prevent sarcopenia progression, according to the Gut Microbes journal 11, 12
Higher fruit and vegetable intake has been associated with greater muscle mass and strength in older adults, as reported in the Gut Microbes journal 12
Potential B vitamin deficiencies (thiamine, niacin, B6, folate, B12) should be evaluated and corrected, as these deficiencies can impair neuromuscular function and mimic or aggravate sarcopenia, according to Nutrition Research Reviews 13
Protein intake >1.0 g/kg body weight daily, distributed throughout the day, with 20-30g per meal, preferably from high-quality, leucine-rich protein sources, is recommended by the Gut Microbes journal 11, 12

Screening and Prevention

Screening for B vitamin deficiencies, particularly B12, folate, and B6, which can cause neuromuscular dysfunction mimicking sarcopenia, is important, as noted in Nutrition Research Reviews 13

Sarcopenia Treatment in Older Adults

Exercise and Nutrition

Progressive resistance training for 12 weeks results in approximately 1.5 kg gain in muscle mass in older adults, with this approach forming the cornerstone of sarcopenia management, as reported by Clinical Nutrition in 2020 14
Endurance training is encouraged for all patients with sarcopenia, as stated in Clinical Nutrition in 2019 15
Seven days of bedrest results in 1 kg loss of lean leg muscle mass in older adults, making muscle preservation during hospitalization critical, according to Clinical Nutrition in 2020 14
Beta-hydroxy-beta-methylbutyrate (HMB) supplementation during bedrest significantly reduced muscle loss and enhanced muscle mass gain during rehabilitation in controlled trials, as found in Clinical Nutrition in 2020 14

Multifactorial Approach

A comprehensive approach addressing sarcopenia's multifactorial etiology—inadequate nutrition, physical inactivity, micronutrient deficiencies, and age-related physiologic changes—simultaneously, produces superior outcomes, as reported by Clinical Nutrition in 2019 15 and Clinical Nutrition in 2019 16

Sarcopenia Pathophysiology and Contributing Factors

Muscle mass decline begins at age 40 years with an 8% decrease per decade, accelerating to 15% per decade after age 70 years, and inadequate protein and energy intake, malabsorption, and micronutrient deficiencies directly impair muscle maintenance 17
B vitamin deficiencies, particularly thiamine, niacin, B6, folate, and B12, impair neuromuscular function through reduced activity of vitamin-dependent enzymes in mitochondria, increased reactive oxygen species production, and inflammatory responses with microglial activation 18
Vitamin B1 deficiency specifically triggers immune responses that cause irreversible neural tissue loss affecting muscle innervation within 9-11 days 18

Secondary Sarcopenia Mechanisms and Sarcopenic Obesity Pathophysiology

Chronic diseases, such as diabetes, cardiovascular disease, chronic kidney disease, and cancer, accelerate sarcopenia through disease-specific inflammatory pathways and metabolic derangements 19
Obesity stimulates sarcopenia by altering lipid metabolism, promoting insulin resistance, activating inflammatory pathways, and causing fat deposition into skeletal muscle (myosteatosis), leading to worse functional outcomes than either condition alone through synergistic metabolic dysfunction 17, 20
Increased intramuscular fat infiltration (myosteatosis) reduces muscle quality and contractile function 20

Postmenopausal and Inactivity‑Related Muscle Loss in Older Women

Menopause‑Related Accelerated Loss

The first five years after the onset of menopause (approximately mid‑50s) are associated with a rapid decline in bone mineral density of about 2 % per year, followed by a slower decline of roughly 1 % per year for the remainder of life, accompanied by parallel reductions in skeletal muscle mass. 21
Menopause‑induced hormonal changes accelerate bone loss and metabolic alterations that increase sarcopenia risk; however, resistance training has been shown to improve bone mineral density in both pre‑menopausal and post‑menopausal women. 22

Prevalence of Osteoporosis in Late Life

By age 80, approximately 70 % of women meet diagnostic criteria for osteoporosis based on bone density measurements. 21

Effects of Acute Inactivity and Rehabilitation

A 7‑day period of bed rest in older adults leads to a loss of about 1 kg of lean leg muscle mass. 23
To recover this loss, an estimated 12 weeks of resistance‑training is required to regain roughly 1.5 kg of muscle mass. 23